Health & Fitness
Health and Fitness
Health and Fitness 
Wed, June 9, 2010
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
[ Wed, Jun 09th 2010
] - Market Wire
Tue, June 8, 2010
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
[ Tue, Jun 08th 2010
] - Market Wire
Forest Laboratories en TransTech Pharma tekenen licentie-overeenkomst voor ontwikkeling en op de markt brengen van glucokinasev
HIGH POINT, N.C. & NEW YORK--([ BUSINESS WIRE ])--TransTech Pharma, Inc en Forest Laboratories, Inc. (NYSE: FRX), maken vandaag bekend dat TransTech Pharma en Forest Laboratories Holdings Limited, een volledige dochter van Forest Laboratories, Inc. een licentie-overeenkomst zijn aangegaan voor de ontwikkeling en het op de markt brengen van kleine moleculaire verbindingen die zijn ontdekt en doorontwikkeld door TransTech Pharma. De verbindingen zijn functioneel lever-selectieve glucokinase-versnellers (GKA's), die een nieuwe categorie vertegenwoordigen binnen de glucose-verlagende middelen tegen diabetes. De licentie-overeenkomst betekent dat Forest TransTech Pharma een licentie-betaling van 50 miljoen dollar zal doen.
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.